乌帕替尼用于顽固性口腔糜烂性扁平苔藓的治疗。 - Suppr

Suppr

超能文献

Use of upadacitinib for recalcitrant oral erosive lichen planus.

作者信息

Sheehan Connor A, Brownstone Nicholas D, Lee Jason B, Hsu Sylvia

机构信息

Department of Dermatology, Temple University Hospital, Philadelphia, Pennsylvania.

Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.

出版信息

JAAD Case Rep. 2025 Mar 28;60:167-169. doi: 10.1016/j.jdcr.2025.02.042. eCollection 2025 Jun.

DOI:10.1016/j.jdcr.2025.02.042

PMID:40519995

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12164042/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4294/12164042/55ce34d69976/gr1.jpg

相似文献

Use of upadacitinib for recalcitrant oral erosive lichen planus.

JAAD Case Rep. 2025 Mar 28;60:167-169. doi: 10.1016/j.jdcr.2025.02.042. eCollection 2025 Jun.

Successful treatment of erosive lichen planus with Upadacitinib complicated by oral squamous cell carcinoma.

SAGE Open Med Case Rep. 2023 Nov 16;11:2050313X231213144. doi: 10.1177/2050313X231213144. eCollection 2023.

Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast.

J Dermatol Case Rep. 2016 Nov 30;10(3):56-57. doi: 10.3315/jdcr.2016.1232.

Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus.

J Dent Res Dent Clin Dent Prospects. 2013;7(2):91-4. doi: 10.5681/joddd.2013.016. Epub 2013 May 30.

Psychological health in patients with genital and oral erosive lichen planus.

J Eur Acad Dermatol Venereol. 2006 Jul;20(6):661-6. doi: 10.1111/j.1468-3083.2006.01559.x.

Treatment of Oral Erosive Lichen Planus With Upadacitinib.

JAMA Dermatol. 2022 Apr 1;158(4):457-458. doi: 10.1001/jamadermatol.2022.0147.

Evaluation of the serum zinc level in erosive and non-erosive oral lichen planus.

J Dent (Shiraz). 2014 Jun;15(2):52-6.

Prevalence of Candida species in erosive oral lichen planus.

J Dent Res Dent Clin Dent Prospects. 2010 Winter;4(1):14-6. doi: 10.5681/joddd.2010.004. Epub 2010 Mar 14.

A Novel Approach to Differentiating Erosive and Reticular Lichen Planus Based on the Percentage of Dental Surfaces With Metal Restorations.

Cureus. 2023 Sep 6;15(9):e44782. doi: 10.7759/cureus.44782. eCollection 2023 Sep.

[Photopheresis: an alternative therapeutic approach in corticoresistant erosive oral lichen planus].

Ann Dermatol Venereol. 2008 Mar;135(3):209-12. doi: 10.1016/j.annder.2007.06.010. Epub 2008 Mar 4.

本文引用的文献

Oral Lichen Planus: A Narrative Review Navigating Etiologies, Clinical Manifestations, Diagnostics, and Therapeutic Approaches.

J Clin Med. 2024 Sep 5;13(17):5280. doi: 10.3390/jcm13175280.

Oral Lichen Planus Successfully Treated With Upadacitinib.

J Drugs Dermatol. 2024 Apr 1;23(4):e104-e106. doi: 10.36849/JDD.7859.

Successful treatment of erosive lichen planus with Upadacitinib complicated by oral squamous cell carcinoma.

SAGE Open Med Case Rep. 2023 Nov 16;11:2050313X231213144. doi: 10.1177/2050313X231213144. eCollection 2023.

Upadacitinib: Mechanism of action, clinical, and translational science.

Clin Transl Sci. 2024 Jan;17(1):e13688. doi: 10.1111/cts.13688. Epub 2023 Dec 18.

CD8 tissue-resident memory T cells induce oral lichen planus erosion via cytokine network.

Elife. 2023 Aug 9;12:e83981. doi: 10.7554/eLife.83981.

The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review.

J Cutan Med Surg. 2023 May-Jun;27(3):271-276. doi: 10.1177/12034754231156100. Epub 2023 Feb 23.

Treatment of Oral Erosive Lichen Planus With Upadacitinib.

JAMA Dermatol. 2022 Apr 1;158(4):457-458. doi: 10.1001/jamadermatol.2022.0147.

Immune mechanisms in oral lichen planus.

Oral Dis. 2023 May;29(4):1400-1415. doi: 10.1111/odi.14142. Epub 2022 Feb 8.

Alleviation of erosive oral and esophageal lichen planus by the JAK1 inhibitor upadacitinib.

J Dtsch Dermatol Ges. 2021 Dec;19(12):1778-1780. doi: 10.1111/ddg.14612. Epub 2021 Nov 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Use of upadacitinib for recalcitrant oral erosive lichen planus.

JAAD Case Rep. 2025 Mar 28;60:167-169. doi: 10.1016/j.jdcr.2025.02.042. eCollection 2025 Jun.

Successful treatment of erosive lichen planus with Upadacitinib complicated by oral squamous cell carcinoma.

SAGE Open Med Case Rep. 2023 Nov 16;11:2050313X231213144. doi: 10.1177/2050313X231213144. eCollection 2023.

Treatment of recalcitrant erosive oral lichen planus and desquamative gingivitis with oral apremilast.

J Dermatol Case Rep. 2016 Nov 30;10(3):56-57. doi: 10.3315/jdcr.2016.1232.

Serum Level of Interleukin 17 in Patients with Erosive and Non erosive Oral Lichen Planus.

J Dent Res Dent Clin Dent Prospects. 2013;7(2):91-4. doi: 10.5681/joddd.2013.016. Epub 2013 May 30.

Psychological health in patients with genital and oral erosive lichen planus.

J Eur Acad Dermatol Venereol. 2006 Jul;20(6):661-6. doi: 10.1111/j.1468-3083.2006.01559.x.

Treatment of Oral Erosive Lichen Planus With Upadacitinib.

JAMA Dermatol. 2022 Apr 1;158(4):457-458. doi: 10.1001/jamadermatol.2022.0147.

Evaluation of the serum zinc level in erosive and non-erosive oral lichen planus.

J Dent (Shiraz). 2014 Jun;15(2):52-6.

Prevalence of Candida species in erosive oral lichen planus.

J Dent Res Dent Clin Dent Prospects. 2010 Winter;4(1):14-6. doi: 10.5681/joddd.2010.004. Epub 2010 Mar 14.

A Novel Approach to Differentiating Erosive and Reticular Lichen Planus Based on the Percentage of Dental Surfaces With Metal Restorations.

Cureus. 2023 Sep 6;15(9):e44782. doi: 10.7759/cureus.44782. eCollection 2023 Sep.

[Photopheresis: an alternative therapeutic approach in corticoresistant erosive oral lichen planus].

Ann Dermatol Venereol. 2008 Mar;135(3):209-12. doi: 10.1016/j.annder.2007.06.010. Epub 2008 Mar 4.

本文引用的文献

Oral Lichen Planus: A Narrative Review Navigating Etiologies, Clinical Manifestations, Diagnostics, and Therapeutic Approaches.

J Clin Med. 2024 Sep 5;13(17):5280. doi: 10.3390/jcm13175280.

Oral Lichen Planus Successfully Treated With Upadacitinib.

J Drugs Dermatol. 2024 Apr 1;23(4):e104-e106. doi: 10.36849/JDD.7859.

Successful treatment of erosive lichen planus with Upadacitinib complicated by oral squamous cell carcinoma.

SAGE Open Med Case Rep. 2023 Nov 16;11:2050313X231213144. doi: 10.1177/2050313X231213144. eCollection 2023.

Upadacitinib: Mechanism of action, clinical, and translational science.

Clin Transl Sci. 2024 Jan;17(1):e13688. doi: 10.1111/cts.13688. Epub 2023 Dec 18.

CD8 tissue-resident memory T cells induce oral lichen planus erosion via cytokine network.

Elife. 2023 Aug 9;12:e83981. doi: 10.7554/eLife.83981.

The Use of Janus Kinase Inhibitors for Lichen Planus: An Evidence-Based Review.

J Cutan Med Surg. 2023 May-Jun;27(3):271-276. doi: 10.1177/12034754231156100. Epub 2023 Feb 23.

Treatment of Oral Erosive Lichen Planus With Upadacitinib.

JAMA Dermatol. 2022 Apr 1;158(4):457-458. doi: 10.1001/jamadermatol.2022.0147.

Immune mechanisms in oral lichen planus.

Oral Dis. 2023 May;29(4):1400-1415. doi: 10.1111/odi.14142. Epub 2022 Feb 8.

Alleviation of erosive oral and esophageal lichen planus by the JAK1 inhibitor upadacitinib.

J Dtsch Dermatol Ges. 2021 Dec;19(12):1778-1780. doi: 10.1111/ddg.14612. Epub 2021 Nov 11.